sirturo
janssen-cilag (new zealand) ltd - bedaquiline fumarate 120.89mg equivalent to bedaquiline 100 mg; ; - tablet - 100 mg - active: bedaquiline fumarate 120.89mg equivalent to bedaquiline 100 mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 20 - sirturo is indicated in adult (greater than or equal to 18 years) and pediatric patients (12 years to less than 18 years of age and weighing at least 30 kg) as part of combination therapy of pulmonary tuberculosis (tb) due to multi-drug resistant mycobacterium tuberculosis.
neomycin 500mg tablets
a a h pharmaceuticals ltd - neomycin sulfate - oral tablet - 500mg
nivemycin 500mg tablets
advanz pharma - neomycin sulfate - oral tablet - 500mg
neomycin 500mg tablets
alliance healthcare (distribution) ltd - neomycin sulfate - oral tablet - 500mg
neomycin 500mg tablets
teva uk ltd - neomycin sulfate - oral tablet - 500mg
neomycin 500mg tablets
advanz pharma - neomycin sulfate - oral tablet - 500mg
streptin injection 1gm
sm pharmaceuticals sdn. bhd. - streptomycin sulphate -
suxamethonium chloride injection bp
suxamethonium chloride -
rapaid itch relief cream
mundipharma pty ltd - melaleuca oil -
suxamethonium chloride bp
juno pharmaceuticals nz limited - suxamethonium chloride dihydrate 50 mg/ml; - solution for injection - 50 mg/ml - active: suxamethonium chloride dihydrate 50 mg/ml excipient: hydrochloric acid sodium hydroxide water for injection - for the production of skeletal muscle relaxation in anaesthesia. suited for procedures requiring only brief relaxation such as endotracheal intubation, endoscopic examinations, orthopaedic manipulations, short surgical procedures and electro-convulsive therapy.